Kite Pharma's change in receivables for the quarter that ended in Jun. 2017 was $0.00 Mil. It means Kite Pharma's Accounts Receivable
stayed the same
from Mar. 2017 to Jun. 2017 .
Kite Pharma's change in receivables for the fiscal year that ended in Dec. 2016 was $0.00 Mil. It means Kite Pharma's Accounts Receivable
stayed the same
from Dec. 2015 to Dec. 2016 .
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Kite Pharma's Days Sales Outstanding for the
three
months ended in Jun. 2017 was 0.00.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Kite Pharma's liquidation value for the
three
months ended in Jun. 2017 was $583.25 Mil.
Kite Pharma Change In Receivables Historical Data
The historical data trend for Kite Pharma's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kite Pharma (NAS:KITE) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Kite Pharma's Days Sales Outstanding for the quarter that ended in Jun. 2017 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kite Pharma Change In Receivables Related Terms
Thank you for viewing the detailed overview of Kite Pharma's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Kite Pharma is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products. In partnership with the National Cancer Institute through a cooperative research and development agreement, Kite is advancing a pipeline of proprietary product candidates, both chimeric antigen receptor and T-cell receptor products, targeting a wide range of cancer indications. The company also has a strategic collaboration with Amgen to develop and commercialize next-generation CAR-T therapies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KITE has been successfully added to your 